Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Intervalo de año de publicación
1.
Pancreas ; 39(1): 16-9, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19752769

RESUMEN

OBJECTIVE: Our aim was to study the therapeutic effects and the mechanism of combination of hemofiltration (HF) and peritoneal dialysis (PD) in the treatment of severe acute pancreatitis (SAP). METHODS: Fifty-one cases of SAP were randomly divided into the HF+PD group (treated group, 36 patients) and the non-HF+PD group (control group, 15 patients). Both groups were treated by the same traditional methods. The relief time of abdominal pain and abdominal distension, computed tomographic scores, acute physiology and chronic health enquiry II scores, length of stay, cost of hospitalization, operability, and recovery rate of the 2 groups were compared. The concentration of tumor necrosis factor-alpha, IL-6, and IL-8 in serum and ascites volumes was determined before and after treatment. RESULTS: : The mean time of abdominal pain relief, amelioration of abdominal distension, decrease of computed tomographic scores, acute physiology and chronic health enquiry II scores, the mean length of stay, and cost of hospitalization of the treated group were significantly shorter or less than those of the control group. The aforementioned inflammatory cytokines, detected at the end of 1 day and 2 days after HF+PD treatment, were decreased significantly compared with those observed in pretherapy and the control group. CONCLUSIONS: Inflammatory cytokines, which overproduced in SAP, can be eliminated effectively from the blood and the ascites by HF+PD treatment.


Asunto(s)
Hemofiltración , Pancreatitis/terapia , Diálisis Peritoneal , APACHE , Enfermedad Aguda , Adulto , Anciano , Terapia Combinada , Humanos , Interleucina-6/sangre , Interleucina-8/sangre , Tiempo de Internación/economía , Persona de Mediana Edad , Pancreatitis/sangre , Pancreatitis/patología , Resultado del Tratamiento , Factor de Necrosis Tumoral alfa/sangre
2.
Inflamm Res ; 59(1): 31-9, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19655231

RESUMEN

OBJECTIVE: To investigate the effect of dexamethasone on the expression levels of P-selectin protein in multiple organs of rats with severe acute pancreatitis (SAP). METHODS: Rats were randomly divided into sham-operated, model control, and dexamethasone-treated groups. At 3, 6, and 12 h after operation, the expression levels of P-selectin protein in one-third of the rats in each group were observed. RESULTS: In the treated group, the expression levels of P-selectin protein in the pancreas head (at 6 h), lung (at 12 h), liver (at 3 h), and spleen (at 6 and 12 h) were significantly lower than those in the model control group (P < 0.05). Additionally, the products of the staining intensity and positive rate of P-selectin protein in liver (at 3 h), lung (at 6 and 12 h), and spleen (at 12 h) in the treated group were significantly lower than those in the model control group (P < 0.05). CONCLUSIONS: Dexamethasone can inhibit P-selectin protein expression in multiple organs of SAP rats.


Asunto(s)
Antiinflamatorios/uso terapéutico , Dexametasona/uso terapéutico , Selectina-P/metabolismo , Pancreatitis/tratamiento farmacológico , Pancreatitis/metabolismo , Enfermedad Aguda , Animales , Modelos Animales de Enfermedad , Riñón/metabolismo , Riñón/patología , Hígado/metabolismo , Hígado/patología , Pulmón/metabolismo , Pulmón/patología , Masculino , Páncreas/metabolismo , Páncreas/patología , Pancreatitis/patología , Ratas , Ratas Sprague-Dawley , Índice de Severidad de la Enfermedad , Bazo/metabolismo , Bazo/patología
3.
Inflammation ; 32(4): 218-32, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19434485

RESUMEN

To observe the protective effects of Salvia miltiorrhizae injection on multiple organs of rats with SAP or OJ. Two hundred eighty-eight rats were used for SAP-associated experiments and OJ-associated experiments. The rats were randomly divided into sham-operated, model control and treated group. According to the different time points after operation, the SAP rats in each group were subdivided into 3, 6 and 12 h groups while the OJ rats were divided into 7, 14, 21 and 28 days groups. The mortality rates, pathological changes and ICAM-1 (only in lung), TLR4 (only in liver), Bax and NF-kappaB proteins expression in multiple organs (liver, kidney, lung, intestinal mucosa, spleen, thymus and lymph nodes) were observed, respectively. The mortality rates of treated groups decreased in both SAP and OJ experiments. Compared to model control group, the pathological changes can be seen in treated groups including; (1) the pathological changes of multiple organs in SAP and OJ experiments were improved, the pathological severity scores of kidney (at 6 h), intestinal mucosa (at 12 h), spleen (at 6 and 12 h), thymus (at 3 and 6 h) and lymph nodes (at 3 and 6 h) in SAP experiment and of liver (on 21 and 28 days), lung (21 days), intestinal mucosa (on 21 and 28 days) and spleen (on 21 and 28 days) in OJ experiment significantly declined (P < 0.05 or P < 0.01); (2) the positive rate of Bax protein in pancreas (at 3 h) and liver (on 6 and 12 h) in SAP experiment and in liver (on 28 days), kidney (on 21 days), and thymus (on 28 days) in OJ experiment were significantly lower (P < 0.05 or P < 0.01); (3) the positive rate of NF-kappaB in liver (at 12 h) and kidney (at 6 h) in SAP experiment and in liver (on 21 days), kidney (on 28 days), intestinal mucosa (on 28 days) and thymus (on 14 days) in OJ experiment significantly decreased (P < 0.05). (4) the positive rate of ICAM-1 in lungs (at 12 h) in SAP experiment was significantly less (P < 0.05). Salvia miltiorrhizae injection can protect multiple organs of SAP or OJ rats and inhibit the expression of ICAM-1, TLR4, NF-kappaB and regulate Bax proteins. Salvia miltiorrhizae may relieve the inflammation response and enhance the immunity function of SAP and OJ rats.


Asunto(s)
Regulación de la Expresión Génica/efectos de los fármacos , Ictericia Obstructiva/tratamiento farmacológico , Pancreatitis/tratamiento farmacológico , Fitoterapia/métodos , Salvia , Enfermedad Aguda , Animales , Molécula 1 de Adhesión Intercelular/genética , Ictericia Obstructiva/mortalidad , Ictericia Obstructiva/patología , FN-kappa B/genética , Especificidad de Órganos , Pancreatitis/mortalidad , Pancreatitis/patología , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Ratas , Índice de Severidad de la Enfermedad , Tasa de Supervivencia , Receptor Toll-Like 4/genética , Proteína X Asociada a bcl-2/genética
4.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-675761

RESUMEN

Objective To study the change of pancreatic microcirculation in the early phase of acute pancreatitis. Methods Literatures on acute pancreatitis and microcirculation were collected and reviewed.Results Pancreatic microcirculation has changed in the early phase of acute pancreatitis, including contraction of interlobular arteriole, slowing of blood fluid, increasing of pancreatic vascular permeability, leukocyte adherence in postcapillary venules, and decreasing of pancreatic perfusion.Conclusion Impairment of pancreatic microcirculation in the early phase of acute pancreatitis may play a key role in the progression of this disease.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA